Re:: Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors

被引:4
|
作者
Campiglio, M
Normanno, N
Ménard, S
机构
[1] Ist Nazl Tumori, Dept Expt Oncol, Mol Targeting Unit, I-20133 Milan, Italy
[2] INT Fdn Pascale, Naples, Italy
来源
关键词
D O I
10.1093/jnci/djh126
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:715 / 715
页数:1
相关论文
共 50 条
  • [1] Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors
    Lu, CH
    Speers, C
    Zhang, Y
    Xu, XC
    Hill, J
    Steinbis, E
    Celestino, J
    Shen, Q
    Kim, H
    Hilsenbeck, S
    Mohsin, SK
    Wakeling, A
    Osborne, CK
    Brown, PH
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (24) : 1825 - 1833
  • [2] Effect of Lapatinib on the Development of Estrogen Receptor-Negative Mammary Tumors in Mice
    Strecker, Tracy E.
    Shen, Qiang
    Zhang, Yun
    Hill, Jamal L.
    Li, Yuxin
    Wang, Chunyu
    Kim, Hee-Tae
    Gilmer, Tona M.
    Sexton, Krystal R.
    Hilsenbeck, Susan G.
    Osborne, C. Kent
    Brown, Powel H.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (02): : 107 - 113
  • [3] Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth
    Zeps, N
    Bentel, JM
    Papadimitriou, JM
    D'Antuono, MF
    Dawkins, HJS
    DIFFERENTIATION, 1998, 62 (05) : 221 - 226
  • [4] Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor-Negative Mammary Tumors
    Shen, Qiang
    Uray, Ivan P.
    Li, Yuxin
    Zhang, Yun
    Hill, Jamal
    Xu, Xiao-Chun
    Young, Matthew R.
    Gunther, Edward J.
    Hilsenbeck, Susan G.
    Colburn, Nancy H.
    Chodosh, Lewis A.
    Brown, Powel H.
    CANCER PREVENTION RESEARCH, 2008, 1 (01) : 45 - 55
  • [5] The challenging estrogen receptor-negative/progesterone receptor-negative/HER-2-negative patient: A promising candidate for epidermal growth factor receptor-targeted therapy?
    Siziopikou, KP
    Ariga, R
    Proussaloglou, KE
    Gattuso, P
    Cobleigh, M
    BREAST JOURNAL, 2006, 12 (04): : 360 - 362
  • [6] Estrogen receptor-negative invasive breast cancer: Imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression
    Wang, Yingbing
    Ikeda, Debra M.
    Narasimhan, Balasubramanian
    Longacre, Teri A.
    Bleicher, Richard J.
    Pal, Sunita
    Jackman, Roger J.
    Jeffrey, Stefanie S.
    RADIOLOGY, 2008, 246 (02) : 367 - 375
  • [7] Combined paclitaxel and cetuximab achieved a major response on the skin metastases of a patient with epidermal growth factor receptor-positive, estrogen receptor-negative, progesterone receptor-negative and human epidermal growth factor receptor-2-negative (tri ple-negative) breast cancer
    Gholam, Dany
    Chebib, Amale
    Hauteville, Dominique
    Bralet, Marie-Pierre
    Jasmin, Claude
    ANTI-CANCER DRUGS, 2007, 18 (07) : 835 - 837
  • [8] Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice
    Laura N Burga
    Hai Hu
    Ashish Juvekar
    Nadine M Tung
    Susan L Troyan
    Erin W Hofstatter
    Gerburg M Wulf
    Breast Cancer Research, 13
  • [9] Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice
    Burga, Laura N.
    Hu, Hai
    Juvekar, Ashish
    Tung, Nadine M.
    Troyan, Susan L.
    Hofstatter, Erin W.
    Wulf, Gerburg M.
    BREAST CANCER RESEARCH, 2011, 13 (02):
  • [10] Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors
    Groheux, David
    Hatt, Mathieu
    Hindie, Elif
    Giacchetti, Sylvie
    de Cremoux, Patricia
    Lehmann-Che, Jacqueline
    Martineau, Antoine
    Marty, Michel
    Cuvier, Caroline
    Cheze-Le Rest, Catherine
    de Roquancourt, Anne
    Visvikis, Dimitris
    Espie, Marc
    CANCER, 2013, 119 (11) : 1960 - 1968